Selective and membrane‐permeable small molecule inhibitors of nicotinamide N‐methyltransferase reverse high fat diet‐induced obesity in mice

[1]  B. Kraus,et al.  Body weight predicts Nicotinamide N-Methyltransferase activity in mouse fat , 2018, Endocrine research.

[2]  B. Desvergne,et al.  From chronic overnutrition to metaflammation and insulin resistance: adipose tissue and liver contributions , 2017, FEBS letters.

[3]  S. Watowich,et al.  Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase. , 2017, Journal of medicinal chemistry.

[4]  P. Pissios.  Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme , 2017, Trends in Endocrinology & Metabolism.

[5]  S. Watowich,et al.  Noncoupled Fluorescent Assay for Direct Real-Time Monitoring of Nicotinamide N-Methyltransferase Activity. , 2017, Biochemistry.

[6]  S. Madsbad,et al.  Emerging drugs for the treatment of obesity , 2017, Expert opinion on emerging drugs.

[7]  B. Kraus,et al.  Quantitative assessment of adipocyte differentiation in cell culture , 2016, Adipocyte.

[8]  Nathan R. Qi,et al.  NAMPT-Mediated NAD(+) Biosynthesis in Adipocytes Regulates Adipose Tissue Function and Multi-organ Insulin Sensitivity in Mice. , 2016, Cell reports.

[9]  S. Koo,et al.  Prdm4 induction by the small molecule butein promotes white adipose tissue browning , 2016, Nature chemical biology.

[10]  Kinyui A. Lo,et al.  Wnt inhibition enhances browning of mouse primary white adipocytes , 2016, Adipocyte.

[11]  J. Rine,et al.  Metabolism and epigenetics. , 2015, Annual review of cell and developmental biology.

[12]  M. Gulliford,et al.  Probability of an Obese Person Attaining Normal Body Weight: Cohort Study Using Electronic Health Records. , 2015, American journal of public health.

[13]  J. Auwerx,et al.  NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. , 2015, Cell metabolism.

[14]  Qingcheng Yang,et al.  Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese. , 2015, The Journal of clinical endocrinology and metabolism.

[15]  John M Asara,et al.  Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization , 2015, Nature Medicine.

[16]  A. Tönjes,et al.  Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance , 2015, Diabetologia.

[17]  D. Guertin,et al.  Rictor/mTORC2 loss in the Myf5 lineage reprograms brown fat metabolism and protects mice against obesity and metabolic disease. , 2014, Cell reports.

[18]  Ji-Eun Lee,et al.  Transcriptional and epigenetic regulation of PPARγ expression during adipogenesis , 2014, Cell & Bioscience.

[19]  Jim Euchner.  Design , 2014, Catalysis from A to Z.

[20]  S. Puri,et al.  Design, synthesis, ADME characterization and antileishmanial evaluation of novel substituted quinoline analogs. , 2014, Bioorganic & medicinal chemistry letters.

[21]  Alexander S. Banks,et al.  Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity , 2014, Nature.

[22]  Janusz Wnek,et al.  2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults , 2013, Circulation.

[23]  K. Brouwer,et al.  Organic Cation Transporter 1 (OCT1/mOct1) Is Localized in the Apical Membrane of Caco-2 Cell Monolayers and Enterocytes , 2013, Molecular Pharmacology.

[24]  K. Inui,et al.  Organic Cation Transporter OCTs (SLC22) and MATEs (SLC47) in the Human Kidney , 2013, The AAPS Journal.

[25]  A. Bstr.  Association of all-cause mortality with overweight and obesity using standard body mass index categories. A systematic review and meta-analysis , 2013, BDJ.

[26]  F. Milagro,et al.  Adiposoft: automated software for the analysis of white adipose tissue cellularity in histological sections , 2012, Journal of Lipid Research.

[27]  J. Auwerx,et al.  The NAD(+) precursor nicotinamide riboside enhances oxidative metabolism and protects against high-fat diet-induced obesity. , 2012, Cell metabolism.

[28]  M. Hann,et al.  Finding the sweet spot: the role of nature and nurture in medicinal chemistry , 2012, Nature Reviews Drug Discovery.

[29]  J. Asara,et al.  A positive/negative ion–switching, targeted mass spectrometry–based metabolomics platform for bodily fluids, cells, and fresh and fixed tissue , 2012, Nature Protocols.

[30]  S. Imai,et al.  Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. , 2011, Cell metabolism.

[31]  S. Gortmaker,et al.  Health and economic burden of the projected obesity trends in the USA and the UK , 2011, The Lancet.

[32]  R. Sigal,et al.  Prescribing Exercise for Individuals with Type 2 Diabetes: Recommendations and Precautions , 2011, The Physician and sportsmedicine.

[33]  José Manuel Fernández-Real,et al.  OCT1 Expression in Adipocytes Could Contribute to Increased Metformin Action in Obese Subjects , 2010, Diabetes.

[34]  F. Hou,et al.  Advanced oxidation protein products inhibit differentiation and activate inflammation in 3T3‐L1 preadipocytes , 2010, Journal of cellular physiology.

[35]  Masashi Okamura,et al.  Role of histone methylation and demethylation in adipogenesis and obesity , 2010, Organogenesis.

[36]  Robert A. Copeland,et al.  Protein methyltransferases as a target class for drug discovery , 2009, Nature Reviews Drug Discovery.

[37]  V. Schramm,et al.  A phosphoenzyme mimic, overlapping catalytic sites and reaction coordinate motion for human NAMPT , 2009, Proceedings of the National Academy of Sciences.

[38]  R. Zechner,et al.  Adipose tissue as a source of nicotinamide N-methyltransferase and homocysteine. , 2009, Atherosclerosis.

[39]  S. Imai.  The NAD World: A New Systemic Regulatory Network for Metabolism and Aging—Sirt1, Systemic NAD Biosynthesis, and Their Importance , 2009, Cell Biochemistry and Biophysics.

[40]  S. Imai,et al.  Age‐associated loss of Sirt1‐mediated enhancement of glucose‐stimulated insulin secretion in beta cell‐specific Sirt1‐overexpressing (BESTO) mice , 2008, Aging cell.

[41]  Sun Tian,et al.  Molecular processes during fat cell development revealed by gene expression profiling and functional annotation , 2005, Genome Biology.

[42]  Michael J Thun,et al.  Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. , 2003, The New England journal of medicine.

[43]  Jennifer L. Martin,et al.  SAM (dependent) I AM: the S-adenosylmethionine-dependent methyltransferase fold. , 2002, Current opinion in structural biology.

[44]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[45]  Ronette L. Kolotkin,et al.  Quality of life and obesity , 2001, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[46]  R. Weinshilboum,et al.  Human liver nicotinamide N-methyltransferase. cDNA cloning, expression, and biochemical characterization. , 1994, The Journal of biological chemistry.

[47]  T. Alston,et al.  Substrate specificity of nicotinamide methyltransferase isolated from porcine liver. , 1988, Archives of biochemistry and biophysics.

[48]  Gerhard Nahler.  Overweight , 2021, Encyclopedia of Evolutionary Psychological Science.

[49]  Chao-Yung Wang,et al.  A mouse model of diet-induced obesity and insulin resistance. , 2012, Methods in molecular biology.

[50]  W. Kiess,et al.  Therapeutic potential of SIRT1 and NAMPT-mediated NAD biosynthesis in type 2 diabetes. , 2009, Frontiers in bioscience.

[51]  G. Bray,et al.  Obesity , 2008, Annals of Internal Medicine.